The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease
Abstract
CONTEXT: The efficient sequestration of hemoglobin by the red blood cell membrane and the presence of multiple hemoglobin clearance mechanisms suggest a critical need to prevent the buildup of this molecule in the plasma. A growing list of clinical manifestations attributed to hemoglobin release in a variety of acquired and iatrogenic hemolytic disorders suggests that hemolysis and hemoglobinemia should be considered as a novel mechanism of human disease. EVIDENCE ACQUISITION: Pertinent scientific literature databases and references were searched through October 2004 using terms that encompassed various aspects of hemolysis, hemoglobin preparations, clinical symptoms associated with plasma hemoglobin, nitric oxide in hemolysis, anemia, pulmonary hypertension, paroxysmal nocturnal hemoglobinuria, and sickle-cell disease. EVIDENCE SYNTHESIS: Hemoglobin is released into the plasma from the erythrocyte during intravascular hemolysis in hereditary, acquired, and iatrogenic hemolytic conditions. When the capacity of protective hemoglobin-scavenging mechanisms has been saturated, levels of cell-free hemoglobin increase in the plasma, resulting in the consumption of nitric oxide and clinical sequelae. Nitric oxide plays a major role in vascular homeostasis and has been shown to be a critical regulator of basal and stress-mediated smooth muscle relaxation and vasomotor tone, endothelial adhesion molecule expression, and platelet activation and aggregation. Thus, clinical consequences of excessive cell-free plasma hemoglobin levels during intravascular hemolysis or the administration of hemoglobin preparations include dystonias involving the gastrointestinal, cardiovascular, pulmonary, and urogenital systems, as well as clotting disorders. Many of the clinical sequelae of intravascular hemolysis in a prototypic hemolytic disease, paroxysmal nocturnal hemoglobinuria, are readily explained by hemoglobin-mediated nitric oxide scavenging. CONCLUSION: A growing body of evidence supports the existence of a novel mechanism of human disease, namely, hemolysis-associated smooth muscle dystonia, vasculopathy, and endothelial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationRadomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,164
Biliverdin reductase: A major physiologic cytoprotectant
Barañano, D. E., Rao, M., Ferris, C. D., & Snyder, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252626999 · Cited by 1,088
Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., & Kinoshita, T. (1993) · Cell · doi:10.1016/0092-8674(93)90250-t · Cited by 1,029
Biological and clinical significance of haptoglobin polymorphism in humans
Langlois, M. R., & Delanghe, J. R. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.10.1589 · Cited by 930
Natural History of Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Lewis, S. M., Bessler, M., Luzzatto, L., & Dacie, J. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331904 · Cited by 907
Self-citationHillmen, P., Hall, C., Marsh, J. C. W., Elebute, M., Bombara, M. P., Petro, B. E., Cullen, M. J., Richards, S. J., Rollins, S. A., Mojcik, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031688 · Cited by 635
Self-citationBALLARD, S. A., GINGELL, C. J., TANG, K., TURNER, L. A., PRICE, M. E., & NAYLOR, A. M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63299-3 · Cited by 591
Hemoglobin. A biologic fenton reagent.
Sadrzadeh, S. M., Graf, E., Panter, S. S., Hallaway, P. E., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42604-4 · Cited by 588
Nitric oxide dioxygenase: An enzymic function for flavohemoglobin
Gardner, P. R., Gardner, A. M., Martin, L. A., & Salzman, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10378 · Cited by 565
Otterbein, L. E., Zuckerbraun, B. S., Haga, M., Liu, F., Song, R., Usheva, A., Stachulak, C., Bodyak, N., Smith, R. N., Csizmadia, E., et al. (2003) · Nature Medicine · doi:10.1038/nm817 · Cited by 526
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance
Ryter, S. W., Otterbein, L. E., Morse, D., & Choi, A. M. K. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015957026924 · Cited by 497
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476 · cited 1×
“Additionally, haptoglobin-hemoglobin binding to CD163 signals anti-inflammatory IL-10 and HO-1 induction in circulating monocytes.(37) Thus, the antioxidant, anticoagulant, antiproliferative, and vasodilating effects of the CD163/HO-1/ biliverdin reductase systems likely”
BackgroundBilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle
Sedlak, T. W., & Snyder, S. H. (2004) · Pediatrics · doi:10.1542/peds.113.6.1776 · Cited by 440
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
Wagener, F. A. D. T. G., Eggert, A., Boerman, O. C., Oyen, W. J. G., Verhofstad, A., Abraham, N. G., Adema, G., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Blood · doi:10.1182/blood.v98.6.1802 · Cited by 421
Holguin, M. H., Fredrick, L. R., Bernshaw, N. J., Wilcox, L. A., & Parker, C. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114172 · Cited by 403
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene.
Bessler, M., Mason, P. J., Hillmen, P., Miyata, T., Yamada, N., Takeda, J., Luzzatto, L., & Kinoshita, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06240.x · Cited by 389
Self-citationA clinical safety trial of stroma‐free hemoglobin
Savitsky, J. P., Doczi, J., Black, J., & Arnold, J. D. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197823173 · Cited by 359
Causes of death in sickle cell disease: an autopsy study
Manci, E. A., Culberson, D. E., Yang, Y., Gardner, T. M., Powell, R., Haynes, J., Shah, A. K., Mankad, V. N., & Investigators of the Cooperative Study of Sickle Cell Disease (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04594.x · Cited by 350
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 329
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
No scavenging and the hypertensive effect of hemoglobin-based blood substitutes
Olson, J. S., Foley, E. W., Rogge, C., Tsai, A.-L., Doyle, M. P., & Lemon, D. D. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.030 · Cited by 308
Prestera, T., Talalay, P., Alam, J., Ahn, Y. I., Lee, P. J., & Choi, A. M. K. (1995) · Molecular Medicine · doi:10.1007/bf03401897 · Cited by 305
Intravascular flow decreases erythrocyte consumption of nitric oxide
Liao, J. C., W. Hein, T., Vaughn, M. W., Huang, K.-T., & Kuo, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8757 · Cited by 305
Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin
Hess, J. R., MacDonald, V. W., & Brinkley, W. W. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.74.4.1769 · Cited by 299
Cannon, R. O., Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A., Shelhamer, J. H., & Gladwin, M. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12761 · Cited by 299
Self-citationCannon, R. O., Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A., Shelhamer, J. H., & Gladwin, M. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112761 · Cited by 298
Self-citationCardiac involvement in thalassemia intermedia: a multicenter study
Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., & Loukopoulos, D. (2001) · Blood · doi:10.1182/blood.v97.11.3411 · Cited by 298
Neutrophil activation by heme: implications for inflammatory processes
Graça-Souza, A. V., Arruda, M. A. B., de Freitas, M. S., Barja-Fidalgo, C., & Oliveira, P. L. (2002) · Blood · doi:10.1182/blood.v99.11.4160 · Cited by 295
Nitric oxide's reactions with hemoglobin: a view through the SNO-storm
Gladwin, M. T., Lancaster, J. R., Freeman, B. A., & Schechter, A. N. (2003) · Nature Medicine · doi:10.1038/nm0503-496 · Cited by 291
Self-citationPrimary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)
Hall, C., Richards, S., & Hillmen, P. (2003) · Blood · doi:10.1182/blood-2003-01-0009 · Cited by 288
Self-citationNitrosative stress: Metabolic pathway involving the flavohemoglobin
Hausladen, A., Gow, A. J., & Stamler, J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14100 · Cited by 285
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 273
Self-citationNatural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays
Moyo, V. M., Mukhina, G. L., Garrett, E. S., & Brodsky, R. A. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04992.x · Cited by 264
Hemoglobin and the Paracrine and Endocrine Functions of Nitric Oxide
Schechter, A. N., & Gladwin, M. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023045 · Cited by 251
Self-citationXue, M., & Del Bigio, M. R. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00971-x · Cited by 246
Wagener, F. A. D. T. G., Feldman, E., de Witte, T., & Abraham, N. G. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44197 · Cited by 241
The effects of recombinant human hemoglobin on esophageal motor function in humans
Murray, J. A., Ledlow, A., Launspach, J., Evans, D., Loveday, M., & Conklin, J. L. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90584-7 · Cited by 230
Controlled Safety Study of a Hemoglobin-Based Oxygen Carrier, DCLHb, in Acute Ischemic Stroke
Saxena, R., Wijnhoud, A. D., Carton, H., Hacke, W., Kaste, M., Przybelski, R. J., Stern, K. N., & Koudstaal, P. J. (1999) · Stroke · doi:10.1161/01.str.30.5.993 · Cited by 228
Wiedmer, T., Hall, S., Ortel, T., Kane, W., Rosse, W., & Sims, P. (1993) · Blood · doi:10.1182/blood.v82.4.1192.1192 · Cited by 225
Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun, C., Raghavachari, N., Beigel, J. H., Shelhamer, J. H., Danner, R. L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2760 · Cited by 221
Self-citationAscaris haemoglobin is a nitric oxide-activated ‘deoxygenase’
Minning, D. M., Gow, A. J., Bonaventura, J., Braun, R., Dewhirst, M., Goldberg, D. E., & Stamler, J. S. (1999) · Nature · doi:10.1038/46822 · Cited by 217
THROMBO‐EMBOLIC DISEASE AFTER SPLENECTOMY FOR HEREDITARY STOMATOCYTOSIS
Stewart, G. W., Amess, J. A. L., Eber, S. W., Kingswood, C., Lane, P. A., Smith, B. D., & Mentzer, W. C. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4881033.x · Cited by 210
The Binding of Hemoglobin to Haptoglobin and Its Relation to Subunit Dissociation of Hemoglobin
Nagel, R. L., & Gibson, Q. H. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62533-5 · Cited by 202
The rate of oxygen uptake by human red blood cells.
Coin, J. T., & Olson, J. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34185-6 · Cited by 199
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction
Corbin, J. D., Francis, S. H., & Webb, D. J. (2002) · Urology · doi:10.1016/s0090-4295(02)01686-2 · Cited by 189
Pulmonary hypertension in sickle cell disease
Sutton, L. L., Castro, O., Cross, D. J., Spencer, J. E., & Lewis, J. F. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90760-9 · Cited by 184
Eherer, A. J., Schwetz, I., Hammer, H. F., Petnehazy, T., Scheidl, S. J., Weber, K., & Krejs, G. J. (2002) · Gut · doi:10.1136/gut.50.6.758 · Cited by 181
Role for the Salmonella Flavohemoglobin in Protection from Nitric Oxide
Crawford, M. J., & Goldberg, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12543 · Cited by 172
Hirsch, D. P., Holloway, R. H., Tytgat, G. N. J., & Boeckxstaens, G. E. E. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70015-0 · Cited by 168
Studt, J.-D., Hovinga, J. A. K., Antoine, G., Hermann, M., Rieger, M., Scheiflinger, F., & Lämmle, B. (2005) · Blood · doi:10.1182/blood-2004-06-2096 · Cited by 160
Pulmonary Thrombotic Arteriopathy in Patients With Sickle Cell Disease
Adedeji, M. O., Cespedes, J., Allen, K. G., Subramony, C., & Hughson, M. D. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1436-ptaipw · Cited by 155
Cardiopulmonary Assessment in Beta-Thalassemia Major
Grisaru, D., Rachmilewitz, E. A., Mosseri, M., Gotsman, M. S., Lafair, J. S., Okon, E., Goldfarb, A., & Hasin, Y. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1138 · Cited by 155
Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions
Lee, R. L., Neya, K., Svizzero, T., & Vlahakes, G. J. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.1.236 · Cited by 147
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution
Przybelski, R. J., Daily, E. K., Kisicki, J. C., Mattia‐Goldberg, C., Bounds, M. J., & Colburn, W. A. (1996) · Critical Care Medicine · doi:10.1097/00003246-199612000-00011 · Cited by 138
The kidneys in paroxysmal nocturnal hemoglobinuria
Clark, D. A., Butler, S., Braren, V., et al. (1981) · Blood · doi:10.1182/blood.v57.1.83.83 · Cited by 135
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide
Schäfer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. K., & Channon, K. M. (2004) · Circulation · doi:10.1161/01.cir.0000126837.88743.dd · Cited by 133
LaMuraglia, G. M., O’Hara, P. J., Baker, W. H., Naslund, T. C., Norris, E. J., Li, J., & Vandermeersch, E. (2000) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(00)90161-7 · Cited by 132
Pulmonary hypertension in patients with thalassemia major
Derchi, G., Fonti, A., Forni, G. L., Galliera, E. O. O., Cappellini, M. D., & Turati, F. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70129-8 · Cited by 123
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse
Kaul, D. K., Liu, X.-D., Fabry, M. E., & Nagel, R. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1799 · Cited by 122
Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders
Atichartakarn, V., Likittanasombat, K., Chuncharunee, S., Chandanamattha, P., Worapongpaiboon, S., Angchaisuksiri, P., & Aryurachai, K. (2003) · International Journal of Hematology · doi:10.1007/bf02983382 · Cited by 121
Hemolytic anemias: Diagnosis and Management
Tabbara, I. A. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30345-5 · Cited by 116
Eberhardt, R. T., McMahon, L. C., Duffy, S. J., Steinberg, M. H., Perrine, S. P., Loscalzo, J., Coffman, J. D., & Vita, J. A. (2003) · American Journal of Hematology · doi:10.1002/ajh.10387 · Cited by 116
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 109
Hebbel, R. P. (1985) · Clinics in Haematology · doi:10.1016/s0308-2261(21)00465-3 · Cited by 109
Hayag-Barin, J. E., Smith, R. E., & Tucker, F. C. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199801)57:1<82::aid-ajh15>3.0.co;2-b · Cited by 108
Regulatory control of complement on blood platelets
Sims, P. J., Rollins, S. A., & Wiedmer, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47291-8 · Cited by 106
Valla, D. C., Dhumeaux, D., Babany, G., Hillon, P., RUEFF, B., Rochant, H., & Benhamou, J. P. (1987) · PubMed · Cited by 106
Broekman, M., Eiroa, A. M., & Marcus, A. (1991) · Blood · doi:10.1182/blood.v78.4.1033.1033 · Cited by 104
Pulmonary Hypertension in Sickle Cell Disease
Vichinsky, E. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038250 · Cited by 101
Evidence for a metabolic shift of arginine metabolism in sickle cell disease
Schnog, J. B., Jager, E. H., van der Dijs, F. P. L., Duits, A. J., Moshage, H. J., Muskiet, F. D., & Muskiet, F. A. J. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0856-9 · Cited by 101
Right ventricular cardiomyopathy in β-thalassaemia major
Hahalis, G. N., Manolis, A. S., Apostolopoulos, D., Alexopoulos, D. K., Vagenakis, A. G., & Zoumbos, N. C. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2709 · Cited by 95
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease
Nath, K. A., Shah, V. H., Haggard, J. J., Croatt, A. J., Smith, L. A., Hebbel, R. P., & Katušić, Z. S. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.6.r1949 · Cited by 94
Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency
Chou, R., & DeLoughery, T. G. (2001) · American Journal of Hematology · doi:10.1002/ajh.1107 · Cited by 93
Enhancement of Platelet Deposition by Cross-Linked Hemoglobin in a Rat Carotid Endarterectomy Model
Olsen, S. B., Tang, D. B., Jackson, M. R., Gomez, E. R., Ayala, B., & Alving, B. M. (1996) · Circulation · doi:10.1161/01.cir.93.2.327 · Cited by 88
Coronary constrictor effect of stroma-free hemoglobin solutions
Vogel, W. M., Dennis, R. C., Cassidy, G. P., Apstein, C. S., & VALERI, C. R. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.251.2.h413 · Cited by 84
Hartmann, R. C., JENKINS, D. E., McKee, L. C., & Heyssel, R. M. (1966) · Medicine · doi:10.1097/00005792-196609000-00001 · Cited by 81
Delayed pulmonary hypertension following splenectomy for congenital spherocytosis
Jardine, D. L., & Laing, A. D. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.00580.x · Cited by 81
Ulatowski, J. A., Nishikawa, T., Matheson-Urbaitis, B., Bucci, E. M., Traystman, R. J., & Koehler, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199604000-00003 · Cited by 76
Inhibition of Clotting Factor XIII Activity by Nitric Oxide
Catani, M. V., Bernassola, F., Rossi, A., & Melino, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9130 · Cited by 74
Plasma Hemoglobin and Hemoglobin Fractions in Sickle Cell Crisis
Naumann, H. N., Diggs, L. W., Barreras, L., & Williams, B. J. (1971) · American Journal of Clinical Pathology · doi:10.1093/ajcp/56.2.137 · Cited by 71
Jaïs, X., Till, S. J., Cynober, T., Ioos, V., Garcia, G., Tchernia, G., Dartevelle, P., Simonneau, G., Delaunay, J., & Humbert, M. J. C. (2003) · Hemoglobin · doi:10.1081/hem-120023377 · Cited by 70
Nakai, K., Ohta, T., Sakuma, I., Akama, K., Kobayashi, Y., Tokuyama, S., Kitabatake, A., Nakazato, Y., Takahashi, T. A., & Sekiguchi, S. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199607000-00018 · Cited by 68
Pulmonary Hypertension in Paroxysmal Nocturnal Hemoglobinuria
Heller, P. G., Grinberg, A. R., Lencioni, M., Molina‐Molina, M., & Roncoroni, A. J. (1992) · CHEST Journal · doi:10.1378/chest.102.2.642 · Cited by 63
Disposal of plasma heme in normal man and patients with intravascular hemolysis
Sears, D. A. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106222 · Cited by 63
Jison, M. L., & Gladwin, M. T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2304002 · Cited by 59
Self-citationde Figueiredo, L. F. P., Mathru, M., Solanki, D. R., Macdonald, V. W., Hess, J. R., & Kramer, G. C. (1997) · doi:10.1097/00005373-199705000-00015 · Cited by 58
Protective Role of Nitric Oxide in a Model of Thrombotic Microangiopathy in Rats
Shao, J., Miyata, T., Yamada, K., Hanafusa, N., WADA, T., GORDON, K. L., Inagi, R., Kurokawa, K., Fujita, T., Johnson, R. J., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102088 · Cited by 52
Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship?
Verresen, D., Backer, W. D., van Meerbeeck, J. P., Neetens, I., Marck, E. V., & Vermeire, P. A. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04050629 · Cited by 46
Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassaemia major
Zakynthinos, E. G. (2001) · Thorax · doi:10.1136/thorax.56.9.737 · Cited by 46
Arginase activity in erythrocytes of healthy and ill children
Azizi, E., Dror, Y., & Wallis, K. T. (1970) · Clinica Chimica Acta · doi:10.1016/0009-8981(70)90063-x · Cited by 45
Deem, S. A., Kim, J.-U., Manjula, B. N., Acharya, A. S., Kerr, M. E., Patel, R. P., Gladwin, M. T., & Swenson, E. R. (2002) · Circulation Research · doi:10.1161/01.res.0000036268.47509.02 · Cited by 43
Self-citationMicroangiopathic Hemolytic Anemia and Thrombocytopenia in Primary Pulmonary Hypertension
Stuard, I. D., Heusinkveld, R. S., & Moss, A. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871710 · Cited by 41
Effect of Sildenafil on hypertensive lower oesophageal sphincter
Bortolotti, M., Pandolfo, N., Giovannini, M., Mari, C., & Miglioli, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01059.x · Cited by 39
Kayanoki, Y., Kawata, S., Yamasaki, E., Kiso, S., Inoue, S., Tamura, S., Taniguchi, N., & Matsuzawa, Y. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90127-0 · Cited by 38
Primary Pulmonary Hypertension
Jubelirer, S. J. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1221 · Cited by 35
Megson, I. L., Sogo, N., Mazzei, F. A., Butler, A. R., Walton, J. C., & Webb, D. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703731 · Cited by 35
Pulmonary thromboendarterectomy in a case of hereditary stomatocytosis
Murali, B., Drain, A. J., Seller, D., Dunning, J. J., & Vuylsteke, A. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg237 · Cited by 33
Nitric oxide: Biological role and clinical uses
Kannan, M., Guiang, S. F., & Johnson, D. E. (1998) · The Indian Journal of Pediatrics · doi:10.1007/bf02761123 · Cited by 20
Left ventricular filling pressure in sickle cell anemia.
Sl, N., Johnson, C. A., & Lj, H. (1992) · PubMed · Cited by 16
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationThe Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Young, N. S., Schubert, J., Brodsky, R. A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M. O., Nakamura, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061648 · Cited by 1,303
Self-citationMechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationRother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Metadata
- Authors
- Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-04-06
- Volume
- 293
- Issue
- 13
- Pages
- 1653
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2150027863
- Cited by
- 1,557
- References
- 106
- FWCI
- 24.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.